Andrew Cournoyer, RPh, MBA
Articles
New Reimbursement May Level Playing Field for Biosimilars
May 21st 2018The new Bipartisan Budget Act of 2018 (to be in effect on January 2019) institute new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Read More
Why New Reimbursement Guidelines for Biosimilars Could Increase Uptake
May 10th 2018The new Bipartisan Budget Act of 2018, to be in effect on January 2019, institutes new reimbursement guidelines for biosimilars under the Medicare coverage gap discount program that remove disincentives for biosimilar uptake and level the playing field for the future market place.
Read More
Latest Updated Articles
Published: November 5th 2024 | Updated: November 22nd 2024
The Mainstreaming of CAR-T
Published: November 18th 2024 | Updated: November 22nd 2024
FDA Approves First-in-Class Drug for Rare Leukemia
Published: November 19th 2024 | Updated: November 22nd 2024
Lung Association, Merck Partner to Raise Awareness of PAH
Published: May 8th 2024 | Updated: November 22nd 2024
FDA Sets Date for Advisory Committee Meeting for Midomafetamine for PTSD
Published: June 5th 2024 | Updated: November 22nd 2024
Updated: FDA Committee, Concerned about Bias, Votes No on Psychedelic in PTSD
Published: August 12th 2024 | Updated: November 22nd 2024
FDA Issues Complete Response Letter for MDMA-Assisted Therapy for PTSD
